Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Roche recovers marketing rights for beta-blocker in most markets

Feb. 15, 1999

Angiotensin II blocker/diuretic combination product added to Spanish pharmacopeia

Feb. 15, 1999

Results published from preclinical study comparing CVT-510 and diltiazem

Feb. 15, 1999

Na+/H+ antiport inhibitors in development at Synthelabo

Feb. 15, 1999

Focal angiogenic gene therapy as a novel treatment for myocardial ischemia

Feb. 15, 1999

Isotechnika's novel atomic substitution technology yields improved calcium channel blocker

Feb. 11, 1999

Boston team reports further successes with naked DNA gene transfer as therapy for angina

Feb. 10, 1999

Cardioprotective agent JTV-519 evaluated for neuronal effects

Feb. 10, 1999

Orion seeks approval for injectable levosimendan in the U.S.

Feb. 10, 1999

Kitasato investigators discover new microbial-based compound for atherosclerosis

Feb. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...